These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14559394)

  • 1. Iontophoretic R-apomorphine delivery in combination with surfactant pretreatment: in vitro validation studies.
    Li GL; Grossklaus A; Danhof M; Bouwstra JA
    Int J Pharm; 2003 Nov; 266(1-2):61-8. PubMed ID: 14559394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment with a water-based surfactant formulation affects transdermal iontophoretic delivery of R-apomorphine in vitro.
    Li GL; Danhof M; Frederik PM; Bouwstra JA
    Pharm Res; 2003 Apr; 20(4):653-9. PubMed ID: 12739775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iontophoretic delivery of apomorphine. I: In vitro optimization and validation.
    van der Geest R; Danhof M; Boddé HE
    Pharm Res; 1997 Dec; 14(12):1798-803. PubMed ID: 9453071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatment.
    Li GL; de Vries JJ; van Steeg TJ; van den Bussche H; Maas HJ; Reeuwijk HJ; Danhof M; Bouwstra JA; van Laar T
    J Control Release; 2005 Jan; 101(1-3):199-208. PubMed ID: 15588905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iontophoretic delivery of apomorphine: from in-vitro modelling to the Parkinson patient.
    Junginger HE
    Adv Drug Deliv Rev; 2002 Nov; 54 Suppl 1():S57-75. PubMed ID: 12460716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro iontophoresis of R-apomorphine across human stratum corneum. Structure-transport relationship of penetration enhancement.
    Li GL; van der Geest R; Chanet L; van Zanten E; Danhof M; Bouwstra JA
    J Control Release; 2002 Nov; 84(1-2):49-57. PubMed ID: 12399167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application.
    Nugroho AK; Della Pasqua O; Danhof M; Bouwstra JA
    Pharm Res; 2004 Nov; 21(11):1974-84. PubMed ID: 15587918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined chemical and electrical enhancement modulates stratum corneum structure.
    de Graaff AM; Li GL; van Aelst AC; Bouwstra JA
    J Control Release; 2003 Jun; 90(1):49-58. PubMed ID: 12767706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and testing of a new iontophoretic continuous flow through transport cell.
    van der Geest R; Danhof M; Boddé HE
    J Control Release; 1998 Jan; 51(1):85-91. PubMed ID: 9685906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iontophoretic delivery of apomorphine. II: An in vivo study in patients with Parkinson's disease.
    van der Geest R; van Laar T; Gubbens-Stibbe JM; Boddé HE; Danhof M
    Pharm Res; 1997 Dec; 14(12):1804-10. PubMed ID: 9453072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lontophoretic delivery of apomorphine in vitro: physicochemic considerations.
    Li GL; Danhof M; Bouwstra JA
    Pharm Res; 2001 Nov; 18(11):1509-13. PubMed ID: 11758756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal iontophoresis of rotigotine: influence of concentration, temperature and current density in human skin in vitro.
    Nugroho AK; Li G; Grossklaus A; Danhof M; Bouwstra JA
    J Control Release; 2004 Apr; 96(1):159-67. PubMed ID: 15063038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
    Kolli CS; Xiao J; Parsons DL; Babu RJ
    Drug Dev Ind Pharm; 2012 May; 38(5):571-6. PubMed ID: 21980925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compartmental modeling of transdermal iontophoretic transport II: in vivo model derivation and application.
    Nugroho AK; Della-Pasqua O; Danhof M; Bouwstra JA
    Pharm Res; 2005 Mar; 22(3):335-46. PubMed ID: 15835738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
    Dubey S; Kalia YN
    J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal macromolecular delivery: real-time visualization of iontophoretic and chemically enhanced transport using two-photon excitation microscopy.
    Grewal BS; Naik A; Irwin WJ; Gooris G; de Grauw CJ; Gerritsen HG; Bouwstra JA
    Pharm Res; 2000 Jul; 17(7):788-95. PubMed ID: 10990196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
    Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
    Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ion-exchange and iontophoresis-controlled delivery of apomorphine.
    Malinovskaja K; Laaksonen T; Kontturi K; Hirvonen J
    Eur J Pharm Biopharm; 2013 Apr; 83(3):477-84. PubMed ID: 23207323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.